Skip to main content
ASSEMBLY BIOSCIENCES, INC. logo

ASSEMBLY BIOSCIENCES, INC. — Investor Relations & Filings

Ticker · ASMB ISIN · US0453962070 LEI · 5299007Y1X8RBDFT8C40 US Manufacturing
Filings indexed 739 across all filing types
Latest filing 2025-03-20 Regulatory Filings
Country US United States of America
Listing US ASMB

About ASSEMBLY BIOSCIENCES, INC.

https://www.assemblybio.com/

Assembly Biosciences, Inc. is a clinical-stage biotechnology company dedicated to the discovery and development of novel, small molecule antiviral therapeutics. The company leverages its deep expertise in virology to create innovative treatments for serious viral diseases, with a pipeline focused on conditions such as herpesviruses and chronic hepatitis B virus (HBV). Through strategic collaborations, including a partnership with Gilead Sciences, Assembly Biosciences aims to advance next-generation therapies designed to change the treatment paradigm for patients with viral infections.

Recent filings

Filing Released Lang Actions
S-3 Filing
Regulatory Filings
2025-03-20 English
8-K Filing
Regulatory Filings
2025-02-20 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2025-02-14 English
8-K Filing
Regulatory Filings
2025-01-03 English
4 Filing
Director's Dealing
2024-12-31 English
8-K Filing
Regulatory Filings
2024-12-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.